Nuveen Insured New York Tax-Free NRK

$10.84 +0.04 (0.37%)

Valuation

Market cap
—
Revenue TTM
$79,963,758
Net income TTM
$74,065,338
P/E (trailing)
—
P/E (forward)
—
Profit margin
—
Debt to equity
—

Trading

Volume
40,362
Avg volume
164,574
Day's range
$10.84 – $10.87
Shares out
—
Stochastic %K
8%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in undervalued municipal securities and other related investments the income, covered by insurance from insurers with a claims-payi...

Show more

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in undervalued municipal securities and other related investments the income, covered by insurance from insurers with a claims-paying ability, exempt from regular federal and New York income tax and are rated Baa, BBB or better and having an average maturity of 15.98 years. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) New York Municipal Bond Index and the Standard & Poor's (S&P) Insured National Municipal Bond Index. It was formerly known as Nuveen New York AMT-Free Municipal Income Fund. Nuveen New York AMT-Free Quality Municipal Income Fund was formed on July 29, 2002 and is domiciled in the United States.

Industry
Asset Management
Sector
Financial Services
Phone
312 917 7700
Website
https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=NRK
Address
333 West Wacker Drive, Chicago, United States

Latest news

No headlines yet.